Acne vulgaris refers to the pimples, blackheads, or just the “acne” that may break out on your skin. Over-the-counter (OTC) treatments, prescription medication, and lifestyle changes can help manage ...

Acne vulgaris affects over 650 million people worldwide, especially teenagers. About 85% of teens develop acne, and many face emotional struggles because of it.

A sebum-selective 1726-nm laser treatment provides year-long control of moderate-to-severe acne across all skin types, with ...

The first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years launched in the United States in November 2021 after being approved in August 2020. The first-in-class ...

CARLSBAD, Calif. — After Arash Moradzadeh, MD, treated the first 100 consecutive patients in his practice with a 1726-nm laser (AviClear) following its Food and Drug Administration (FDA) clearance for ...

Researchers have created a two-stage acne patch with tiny arrowhead-shaped spikes that deliver healing compounds directly under the skin. Trials showed pimples vanished in seven days, and the ...

Use of oral spironolactone in women with acne vulgaris was effective and not associated with increased adverse event risk compared with placebo.

Acne vulgaris remains one of the most pervasive inflammatory skin conditions worldwide, affecting not only adolescents but also adults and contributing to significant psychosocial burden. The ...

Bausch Health Companies Inc.’s BHC dermatology business, Ortho Dermatologics, announced that the FDA has approved the New Drug Application for its acne lotion Arazlo (tazarotene). Arazlo Lotion 0.045% ...

More than 50 million people affected by acne in US each year, with market valued at $5.7 billion in 2024 WOBURN, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” ...